or Try an Advanced Search...

    Related Disease Stocks List

    Symbol Grade Name % Change
    REGN C Regeneron Pharmaceuticals, Inc. 1.48
    NXTC D NextCure, Inc. 1.21
    NBIX B Neurocrine Biosciences, Inc. 0.27
    IVA F Inventiva S.A. 3.88
    IMRN D Immuron Limited 0.87
    GLTO F Galecto, Inc. -1.41
    GLMD D Galmed Pharmaceuticals Ltd. 1.50
    ERNA C Eterna Therapeutics Inc. -1.48
    View As Page of Charts
    Related Industries: Biotechnology Broadcasting - TV
    Related Stock Lists: Cancer Alcohol Clinical Development Clinical Medicine Immunotherapy Medicine Biology Biopharmaceutical Biotechnology Breakthrough Therapy Cardiovascular Disease Diabetes Disorders Fibrosis Immune Related Diseases Immunology Inflammation Medical Research Non Alcoholic Fatty Liver Disease Pain

    Related ETFs - A few ETFs which own one or more of the above listed Related Disease stocks.

    Symbol Grade Name Weight
    BBH C Market Vectors Biotech ETF 10.61
    PBE C PowerShares Dynamic Biotech & Genome 10.35
    IBB D iShares Nasdaq Biotechnology Index Fund 9.71
    IBBQ C Invesco Nasdaq Biotechnology ETF 9.62
    MNTL D Tema Neuroscience and Mental Health ETF 8.99
    View all Related Disease ETFs...
    Compare ETFs
    Compare BBH to IBBQ Compare PBE to IBB Compare PBE to IBBQ

        Related Disease Stocks Recent News

        Date Stock Title
        May 17 REGN More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
        May 17 REGN Regeneron wins temporary restraining order preventing Eylea generic launch
        May 17 IVA Inventiva receives positive recommendation from DMC for late stage trial of NASH treatment
        May 16 IVA Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH
        May 16 REGN These 2 No-Brainer Growth Stocks Are Breaking New Ground
        May 14 REGN Regeneron Pharmaceuticals Inc (REGN) RBC Capital Markets Global Healthcare Conference (Transcript)
        May 14 REGN Evercore says biotech ‘winter is finally thawing’
        May 14 NBIX Neurocrine Biosciences Presented Baseline Data from the CAHtalyst™ Program in CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ECE 2024
        May 13 IVA Why Is Inventiva's Stock Trading Higher on Monday?
        May 13 REGN Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
        May 13 REGN Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
        May 13 REGN Pipeline Moves: Phase III completion for Corcept’s relaorilant
        May 13 IVA Inventiva announces the publication in Nature Communications of additional results from NATIVE Phase IIb clinical trial demonstrating improvement of markers of cardiometabolic health in patients with MASH/NASH treated with lanifibranor
        May 13 REGN Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
        Related Industries: Biotechnology Broadcasting - TV
        Related Stock Lists: Cancer Alcohol Clinical Development Clinical Medicine Immunotherapy Medicine Biology Biopharmaceutical Biotechnology Breakthrough Therapy Cardiovascular Disease Diabetes Disorders Fibrosis Immune Related Diseases Immunology Inflammation Medical Research Non Alcoholic Fatty Liver Disease Pain
        Related Disease

        Browse All Tags